| pubmed-article:16392026 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0015811 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0205107 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0244404 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:16392026 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:16392026 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16392026 | pubmed:dateCreated | 2006-3-23 | lld:pubmed |
| pubmed-article:16392026 | pubmed:abstractText | Raloxifene improves spine bone mineral density (BMD), and its ability to reduce vertebral fractures by 40-50% suggests that it increases vertebral strength. Positive effects on hip BMD suggest a similar strengthening of the hip, but dimensional ambiguities in BMD by dual energy x-ray absorptiometry (DXA) make it difficult to infer strength effects directly. Hip fractures may be too infrequent to evaluate in practical clinical trials; even the Multiple Outcomes of Raloxifene Evaluation (MORE) study with 7,705 subjects was insufficiently powered to show a comparable reduction in hip fractures. | lld:pubmed |
| pubmed-article:16392026 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16392026 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16392026 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16392026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16392026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16392026 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16392026 | pubmed:issn | 0937-941X | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:DesaiahDD | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:BeckT JTJ | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:HarperK DKD | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:Uusi-RasiKK | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:DaphtaryM MMM | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:CransG GGG | lld:pubmed |
| pubmed-article:16392026 | pubmed:author | pubmed-author:SemanickL MLM | lld:pubmed |
| pubmed-article:16392026 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16392026 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:16392026 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16392026 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16392026 | pubmed:pagination | 575-86 | lld:pubmed |
| pubmed-article:16392026 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:meshHeading | pubmed-meshheading:16392026... | lld:pubmed |
| pubmed-article:16392026 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16392026 | pubmed:articleTitle | Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. | lld:pubmed |
| pubmed-article:16392026 | pubmed:affiliation | Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. | lld:pubmed |
| pubmed-article:16392026 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16392026 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16392026 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16392026 | lld:pubmed |
